Tivantinib for the treatment of hepatocellular carcinoma
Sign Up to like & getrecommendations! Published in 2017 at "Expert Opinion on Pharmacotherapy"
DOI: 10.1080/14656566.2017.1316376
Abstract: ABSTRACT Introduction: Hepatocellular carcinoma (HCC) is one of the leading causes of cancer-related death worldwide with a poor prognosis due to late diagnosis in the majority of cases. Physicians are frequently confronted with patients who… read more here.
Keywords: hepatocellular carcinoma; tivantinib treatment; treatment hepatocellular; treatment ... See more keywords
The effectiveness of tivantinib for MET-high hepatocellular carcinoma: A protocol for meta analysis
Sign Up to like & getrecommendations! Published in 2023 at "Medicine"
DOI: 10.1097/md.0000000000032591
Abstract: Background: The efficacy of tivantinib for MET-high hepatocellular carcinoma remains controversial. We conduct this meta-analysis to explore the efficacy of tivantinib versus placebo for MET-high hepatocellular carcinoma. Methods: We have searched PubMed, EMbase, Web of… read more here.
Keywords: met high; hepatocellular carcinoma; meta analysis; high hepatocellular ... See more keywords